196 related articles for article (PubMed ID: 33551330)
1. Serial 6-month change in forced vital capacity predicts subsequent decline and mortality in Japanese patients with newly diagnosed idiopathic pulmonary fibrosis.
Toi Y; Takei R; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Fukuoka J; Johkoh T; Kondoh Y
Respir Investig; 2021 May; 59(3):335-341. PubMed ID: 33551330
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
Aono Y; Nakamura Y; Kono M; Nakamura H; Yokomura K; Imokawa S; Toyoshima M; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620953783. PubMed ID: 32928050
[TBL] [Abstract][Full Text] [Related]
3. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
[TBL] [Abstract][Full Text] [Related]
4. Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis.
Paterniti MO; Bi Y; Rekić D; Wang Y; Karimi-Shah BA; Chowdhury BA
Ann Am Thorac Soc; 2017 Sep; 14(9):1395-1402. PubMed ID: 28388260
[TBL] [Abstract][Full Text] [Related]
5. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.
Zappala CJ; Latsi PI; Nicholson AG; Colby TV; Cramer D; Renzoni EA; Hansell DM; du Bois RM; Wells AU
Eur Respir J; 2010 Apr; 35(4):830-6. PubMed ID: 19840957
[TBL] [Abstract][Full Text] [Related]
6. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis.
Lee H; Kim SY; Park YS; Choi SM; Lee JH; Park J
Sci Rep; 2024 Apr; 14(1):8857. PubMed ID: 38632477
[TBL] [Abstract][Full Text] [Related]
8. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
9. Predicting pulmonary fibrosis disease course from past trends in pulmonary function.
Schmidt SL; Tayob N; Han MK; Zappala C; Kervitsky D; Murray S; Wells AU; Brown KK; Martinez FJ; Flaherty KR
Chest; 2014 Mar; 145(3):579-585. PubMed ID: 24231810
[TBL] [Abstract][Full Text] [Related]
10. Deterioration of high-resolution computed tomography findings predicts disease progression after initial decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Higo H; Miyahara N; Taniguchi A; Senoo S; Itano J; Watanabe H; Oda N; Kayatani H; Ichikawa H; Shibayama T; Kajimoto K; Tanimoto Y; Kanehiro A; Maeda Y; Kiura K;
Respir Investig; 2020 May; 58(3):185-189. PubMed ID: 32102769
[TBL] [Abstract][Full Text] [Related]
11. Impact of Lung Biopsy on Lung Function in Idiopathic Pulmonary Fibrosis.
Aussedat PH; Chebib N; Ahmad K; Glerant JC; Drevet G; Grima R; Maury JM; Nasser M; Thivolet-Bejui F; Traclet J; Turquier S; Chalabreysse L; Tronc F; Cottin V
Respiration; 2020; 99(12):1101-1108. PubMed ID: 33260187
[TBL] [Abstract][Full Text] [Related]
12. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
[TBL] [Abstract][Full Text] [Related]
14. Texture-Based Automated Quantitative Assessment of Regional Patterns on Initial CT in Patients With Idiopathic Pulmonary Fibrosis: Relationship to Decline in Forced Vital Capacity.
Park HJ; Lee SM; Song JW; Lee SM; Oh SY; Kim N; Seo JB
AJR Am J Roentgenol; 2016 Nov; 207(5):976-983. PubMed ID: 27533069
[TBL] [Abstract][Full Text] [Related]
15. Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.
Serajeddini H; Rogliani P; Mura M
Lung; 2018 Dec; 196(6):707-713. PubMed ID: 30151723
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.
Schmidt SL; Nambiar AM; Tayob N; Sundaram B; Han MK; Gross BH; Kazerooni EA; Chughtai AR; Lagstein A; Myers JL; Murray S; Toews GB; Martinez FJ; Flaherty KR
Eur Respir J; 2011 Jul; 38(1):176-83. PubMed ID: 21148225
[TBL] [Abstract][Full Text] [Related]
17. Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis.
Richeldi L; Ryerson CJ; Lee JS; Wolters PJ; Koth LL; Ley B; Elicker BM; Jones KD; King TE; Ryu JH; Collard HR
Thorax; 2012 May; 67(5):407-11. PubMed ID: 22426899
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and association with survival of respiratory-related hospitalization in Japanese idiopathic pulmonary fibrosis patients.
Nishiyama O; Saeki S; Yamazaki R; Sano H; Iwanaga T; Kume H; Tohda Y
Respir Investig; 2019 Sep; 57(5):415-421. PubMed ID: 31003952
[TBL] [Abstract][Full Text] [Related]
19. Real world experience of response to pirfenidone in patients with idiopathic pulmonary fibrosis: a two centre retrospective study.
Eaden JA; Barber CM; Renshaw SA; Chaudhuri N; Bianchi SM
Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):218-224. PubMed ID: 33093786
[TBL] [Abstract][Full Text] [Related]
20. Serial decline in lung volume parameters on computed tomography (CT) predicts outcome in idiopathic pulmonary fibrosis (IPF).
Robbie H; Wells AU; Fang C; Jacob J; Walsh SLF; Nair A; Camoras R; Desai SR; Devaraj A
Eur Radiol; 2022 Apr; 32(4):2650-2660. PubMed ID: 34716781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
